| A clinical drug development programme to evaluate and compare the safety and efficacy of new regimens of Lifecare's Liposomal Amphotericin b (FUNGISOMETM) against currently accepted therapies for the treatment of Kala Azar; A Phase III, Open Label Randomized Trial of Three Single Dose Treatment regimens of FUNGISOMETM ALONE OR IN Combination with Miltefosine compared with single Dose Treatment regimen of AmBisome for visceral Leishmaniasis in India | Dr. J N Verma, Lifecare Innovations Private Limited, Gurgaon, Haryana (122018) | 2024 | Department of Science and Technology (DST) | Pharmaceutical Sciences |
| Stereoselective Synthesis of Structurally Diverse Sp3-rich Polycyclic Scaffolds: Generation of High valued New Molecular Entities (NMEs) for GPCR Modulators | Dr. Ravindra Kumar, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh | 2024 | Anusandhan National Research Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Cancer environment stimuli-responsive DNA nanoparticles: A unique drug delivery vehicle for combination cancer therapy | Dr. Reji Varghese, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Kerala | 2023 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Novel quinoline-ferrocene hybrids integrated with triazole, benzene and tetrahydropyrimidine rings: Design, synthesis, structure elucidation and anti-malarial activity studies | Dr. Shunan Kaping, Assam DON BOSCO University, Guwahati, Assam (782402) | 2023 | Department of Science and Technology (DST) | Pharmaceutical Sciences |
| Bioisosteric Approach for the Synthesis of Fumitremorgin C, Tariquidar and Elacridar Analogues for Reversing Multidrug Resistance in Cancer | Dr. Neetu Kumari, Mohan Lal Sukhadia University, Rajasthan | 2023 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Development of Functionalized Magnetic nanoparticles with lesser hemolytic activity to enhance drug efficacy for Pharmaceutical industry | Ms. Vandana Agarwal, BBK DAV College for Women, Amritsar, Punjab (143001) | 2023 | Department of Science and Technology (DST) | Pharmaceutical Sciences |
| Lipidic nanotransporter based hydrogel against C. Albican: Herbal blend approach | Ms. Anamika Sahu Gulbake, Girijananda Chowdhury University, Guwahati, Assam | 2023 | Department of Science and Technology (DST) | Pharmaceutical Sciences |
| Molecular explorations of the Leishmania donovani Homoserine Dehydrogenase and evaluating the impact of its perturbations using CRISPR-Cas9 system’’ | Dr. Sushma Singh, Associate Professor, National Institute of Pharmaceutical Education and Research (NIPER), | 2023 | | Pharmaceutical Sciences |
| Unraveling the neuroprotective mechanism of Vitexin and Thymol synergistic combination against tau hyperphosphorylation and neuroinflammation: a therapeutic approach for the treatment of Alzheimer’s disease | Dr. Pandima Devi Kasi, Alagappa University, Tamil Nadu | 2023 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| Development and validation of improved AI/MLbased selectivity models for HDACs, a epigenetic target for cancer, neurodegenerative diseases | Dr. Shovanlal Gayen, Jadavpur University, West Bengal | 2023 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |